FAIZA HAQUE: Open Payments
NPI 1982249728 · PEARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$208 in 10 payments from 6 companies in 2025. Trend: 2023 $1,029 · 2024 $158 · 2025 $208
Food & beverage: $208
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 1 | $28 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
Products named: Auvelity, CAPLYTA, COBENFY, ABILIFY ASIMTUFII, UZEDY, FANAPT, REXULTI.
Industry payments across TX — which companies pay providers there.
